Clinical Trials Browser

Phase 1 × enfortumab vedotin × Tumor-Agnostic × Clear all

NCT01409135 2024-03-12

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Phase 1 Completed

Neoplasms